Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.
about
Prostanoid receptor EP2 as a therapeutic targetTherapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticusEP2 Receptor Signaling Regulates Microglia Death.Evaluation of WO 2012/177618 A1 and US-2014/0179750 A1: novel small molecule antagonists of prostaglandin-E2 receptor EP2.Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to BedsideDefining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.Cyclooxygenase-2 in glioblastoma multiforme.Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype.
P2860
Q33711678-67D2F40E-066B-461B-A9F6-6140FD8EE2F1Q35534894-84C92A59-2C30-4092-B953-0B3A88B1A1A9Q35745955-C442DC34-28D1-43C8-B457-5C7FAE648352Q36833728-093D613C-A4A3-4387-8C61-6DED46E4C495Q37340703-24B5B82C-CF27-4C4B-96B4-9AC4FAB12470Q37350938-0B59EB09-6F4D-4285-848D-8DE1A2A9BFF0Q38969912-FB689EDE-BC33-45FF-9D14-DE6FAE724427Q41533962-E6B01C53-049C-4A87-BFE8-5FF666DACC82
P2860
Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.
@en
Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.
@nl
type
label
Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.
@en
Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.
@nl
prefLabel
Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.
@en
Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.
@nl
P2860
P356
P1476
Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists
@en
P2093
Rangaiah Shashidharamurthy
Thota Ganesh
P2860
P304
P356
10.1021/ML400112H
P577
2013-07-01T00:00:00Z